These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12403936)

  • 1. Aberrant Fas ligand expression in lymphocytes in patients with Behçet's disease.
    Wakisaka S; Takeba Y; Mihara S; Takeno M; Yamamoto S; Sakane T; Suzuki N
    Int Arch Allergy Immunol; 2002 Oct; 129(2):175-80. PubMed ID: 12403936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
    Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
    Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.
    Shukuwa T; Katayama I; Koji T
    Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC).
    Fukuzawa Y; Takahashi K; Furuta K; Tagaya T; Ishikawa T; Wada K; Omoto Y; Koji T; Kakumu S
    J Gastroenterol; 2001 Oct; 36(10):681-8. PubMed ID: 11686478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cigarette smoking on Fas/Fas ligand expression of human lymphocytes.
    Suzuki N; Wakisaka S; Takeba Y; Mihara S; Sakane T
    Cell Immunol; 1999 Feb; 192(1):48-53. PubMed ID: 10066346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
    J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
    Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.
    Lee TB; Min YD; Lim SC; Kim KJ; Jeon HJ; Choi SM; Choi CH
    J Gastroenterol Hepatol; 2002 Jan; 17(1):32-8. PubMed ID: 11895550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice.
    Hagimoto N; Kuwano K; Nomoto Y; Kunitake R; Hara N
    Am J Respir Cell Mol Biol; 1997 Jan; 16(1):91-101. PubMed ID: 8998084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of Fas ligand on anti-DNA autoantibody secreting B lymphocytes in patients with systemic lupus erythematosus: "immune privilege"-like state of the autoreactive B cells.
    Nagafuchi H; Wakisaka S; Takeba Y; Takeno M; Sakane T; Suzuki N
    Clin Exp Rheumatol; 2002; 20(5):625-31. PubMed ID: 12412192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
    Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F
    Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
    Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
    Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease.
    Nagafuchi H; Takeno M; Yoshikawa H; Kurokawa MS; Nara K; Takada E; Masuda C; Mizoguchi M; Suzuki N
    Clin Exp Immunol; 2005 Feb; 139(2):363-70. PubMed ID: 15654836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of Fas-mediated apoptosis in a human renal epithelial cell line by interferon-gamma: involvement of Fas-mediated apoptosis in acute renal rejection.
    Akasaka Y; Ishikawa Y; Kato S; Ishii T; Masuda T; Fujita K; Yamada T; Kawamura S
    Mod Pathol; 1998 Nov; 11(11):1107-14. PubMed ID: 9831209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbed expression of Fas/FasL on CD4(+) and CD8(+)T cells in Behcet's disease, Vogt-Koyanagi-Harada syndrome, and idiopathic anterior uveitis.
    Yang P; Ji L; Zhou H; Huang X; Xie C; Jin H; Chen L; Kijlstra A
    Ocul Immunol Inflamm; 2001 Sep; 9(3):185-91. PubMed ID: 11815887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skewed TGFβ/Smad signalling pathway in T cells in patients with Behçet's disease.
    Shimizu J; Izumi T; Arimitsu N; Fujiwara N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Takai K; Suzuki N
    Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S35-9. PubMed ID: 22935165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis in the course of granulomatous inflammation in pulmonary sarcoidosis.
    Kunitake R; Kuwano K; Miyazaki H; Hagimoto N; Nomoto Y; Hara N
    Eur Respir J; 1999 Jun; 13(6):1329-37. PubMed ID: 10445608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
    Choi HJ; Ku JK; Kim MY; Kang H; Cho SH; Kim HO; Park YM
    Br J Dermatol; 2006 Mar; 154(3):419-25. PubMed ID: 16445769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma.
    Koyama S; Koike N; Adachi S
    J Cancer Res Clin Oncol; 2001 Jan; 127(1):20-6. PubMed ID: 11206267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.